Digital Glucose Monitoring in Gestational Diabetes

Not Applicable

• Conditions: Gestational Diabetes

• Registration Number: NCT02783612
• Lead Sponsor: Wolfson Medical Center

Brief Summary

Assessing blood glucose control in women with gestational diabetes can be challenging. The standard of care remains visual inspection of blood glucose paper diaries of self-performed capillary monitoring during regular meeting in High Risk pregnancy clinics.

The researchers are interested in preforming a randomized control trial comparing women with the diagnosis of gestational diabetes with regular High-Risk clinic surveillance to digital monitoring using an application in a Smart-phone and submitting those values via email in addition to the regular clinic appointments.

The Primary outcome of the trial is to assess the compliance of the research group as compared to the control group.

Detailed Description

Not available

Study Timeline

• Study Start: 2016-03
• Study First Submitted: 2016-04-12
• Status Verified: 2016-05
• Study First Submitted QC: 2016-05-25
• Last Update Submitted: 2016-05-25
• Study First Posted: 2016-05-26
• Last Update Posted: 2016-05-26
• Primary Completion: 2018-07
• Study Completion: 2018-07

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: Female
• Target Recruitment: 100

Inclusion Criteria

• gestational diabetes

Exclusion Criteria

• pre-gestational diabetes

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Assessing the compliance of the research group compared to the control group.	18 month	By calculating the amount of daily glucose measurements in the research group compared to the number of glucose measurements in the control group

Trial Locations

Locations (1)

Wolfson medical center; 🇮🇱 Holon, Israel